SCHEMBL13259019

SCHEMBL13259019

CC1Oc2ccc(Cc3nnc(SCc4cccc(C(F)(F)F)c4F)n3-c3ccc(F)cc3)cc2O1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.42
TP53 P04637 7/20 0.41
MAPT P10636 6/20 0.41
NPSR1 Q6W5P4 3/20 0.40
HTT P42858 2/20 0.40
RECQL P46063 2/20 0.40
ALDH1A1 P00352 5/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HSD17B10 Q99714 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
METAP2 P50579 1/20 0.36
LMNA P02545 2/20 0.35
ALOX15 P16050 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13259015 0.84 GPBAR1 (0.46) GPBAR1SMN1; SMN2TP53MAPTNPSR1
SCHEMBL13259018 0.84 GPBAR1 (0.67) GPBAR1SMN1; SMN2TP53MAPTNPSR1
SCHEMBL10229744 0.82 GPBAR1 (0.70) GPBAR1SMN1; SMN2TP53MAPTNPSR1
SCHEMBL13259977 0.82 GPBAR1 (0.47) GPBAR1SMN1; SMN2TP53MAPTNPSR1
SCHEMBL13259978 0.81 GPBAR1 (0.41) GPBAR1SMN1; SMN2TP53MAPTNPSR1
SCHEMBL13259966 0.80 GPBAR1 (0.59) GPBAR1SMN1; SMN2MAPTNPSR1HTT
SCHEMBL13259016 0.74 SMN1; SMN2 (0.42) GPBAR1SMN1; SMN2TP53MAPTNPSR1
SCHEMBL10229631 0.72 GPBAR1 (0.53) GPBAR1SMN1; SMN2TP53MAPTNPSR1
SCHEMBL10229758 0.71 GPBAR1 (0.47) GPBAR1SMN1; SMN2TP53MAPTNPSR1
SCHEMBL13259961 0.70 GPBAR1 (0.47) GPBAR1SMN1; SMN2MAPTHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO disclosed